Bilateral multifocal pseudomonas aeruginosa keratitis in a contact lens-wearing diabetic patient treated with a custom compounded 5% imipenem-cilastatin topical solution
Abstract
Keywords
Full Text:
PDF - EyeReports 2020 v6 p9-12References
Taher EE, Mahmoud NF, Negm S, et al. Severe, sight threatening microbial keratitis: coinfection of acanthamoeba and Pseudomonas in contact lens associated keratitis. Advances in Environmental Biology 2016; 10: 231–240.
Lakhundi S, Siddiqui R, Khan NA. Pathogenesis of microbial keratitis. Microbial Pathogenesis 2017; 104: 97-109.
Yeung KK, Forister JF, Forister EF, et al. Compliance with soft contact lens replacement schedules and associated contact lens-related ocular complications: the UCLA Contact Lens Study. Optometry 2010; 81(11): 598-607.
Pachigolla G, Blomquist P, Cavanagh HD. Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban country hospital in North Texas. Eye and Contact Lens. 2007; 33: 45–49.
Mah-Sadorra JH, Yavuz SG, Najjar DM, et al. Trends in contact lens-related corneal ulcers. Cornea. 2005; 24(1): 51–58.
Marquart M, O'Callaghan R. Infectious keratitis: secreted bacterial proteins that mediate corneal damage. Journal of Ophthalmology 2013; 36: 90-94.
Li YC, Zeldovich A, Chua BJ, et al. Hazardous contact: a case of visual loss following Pseudomonas keratitis from novelty contact lens wear. Medical Journal of Australia 2006; 185: 173-174.
Evans D, Fleiszig S. Why does the healthy cornea resist pseudomonas aeruginosa infection? American Journal of Ophthalmology 2013; 155: 961-970.
Sizmaz S, Bingollu S, Erdem E, et al. Polymicrobial infection of the cornea due to contact lens wear. Turkish Journal of Ophthalmology 2016; 46: 83-86.
Beattie TK, Tomlinson A. The effect of surface treatment of silicone hydrogel contact lenses on the attachment of acanthamoeba castellanii trophozoites. Eye and Contact Lens. 2009; 6: 316-319.
Musa F, Tailor R, Gao A. Contact lens-related microbial keratitis in deployed British military personel. British Journal of Ophthalmology 2010; 94: 988-993.
Makwana P, Abulafia A, Ondhia C, et al. Severe bilateral pseudomonas keratitis exacerbated by prolonged contact lens wear. Medical Journal of Australia 2014; 201(2): 112-113.
Carey IM, Critchley JA, DeWilde S, et al. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care 2018; 41(3): 513-521.
Sharma S. Antibiotic resistance in ocular bacterial pathogens. Indian Journal of Medical Microbiology 2011;29:218-22.
Mahin SP, Gerami P, Elmi A, et al. Pseudomonas aeruginosa keratitis: passive immunotherapy with antibodies raised against divalent flagellin. Iranian Journal of Basic Medical Sciences 2019; 22(1): 58–64.
Zhou C, Chen X, Wu L, et al. Distribution of drug-resistant bacteria and rational use of clinical antimicrobial agents. Experimental and Therapeutic Medicine 2016; 11(6): 2229-2232.
Ku JY, Kim P, Tong J, et al. Multiresistant pseudomonas keratitis. Clinical and Experimental Ophthalmology 2010; 38(8): 818-9.
Chew FL, Soong TK, Shin HC, et al. Topical piperacillin/tazobactam for recalcitrant pseudomonas aeruginosa keratitis. Journal of Ocular Pharmacolology and Therapeutics 2010; 26: 219–22.
Jain R, Murthy SI, Motukupally SR. Clinical outcomes of corneal graft infections caused by multi-drug resistant Pseudomonas aeruginosa. Cornea 2014; 33: 22–6.
Jain R, Murthy SI, Motukupally SR, et al. Use of topical colistin in multiple drug-resistant Pseudomonas aeruginosa bacterial keratitis. Cornea 2014; 33: 923–7.
Pande R, Bhailume PV. Use of topical meropenem in management of hospital acquired Pseudomonas ocular infections. Journal of Clinical Ophthalmolology and Research 2014; 2:23–5.
Sawusch MR, O’Brien TP, Valentine J, et al. Topical imipenem therapy of aminoglycoside-resistant pseudomonas keratitis in rabbits. American Journal of Ophthalmology 1988; 106: 77-81.
Castro Balado A, García Otero X, Zarra Ferro I, et al. 3PC-034 imipenem-fortified eye drops for the treatment of bacterial keratitis: development and characterisation. European Journal of Hospital Pharmacy 2019; 26: A52.
Cutarelli PE, Lazarus HM, Jacobs MR, et al. Antimicrobial activity and in vitro corneal epithelial toxicity of antimicrobial agents for gram-positive corneal pathogens. Current Eye Research. 1993; 12(7): 603-8.
DOI: http://dx.doi.org/10.16964/er.v6i1.92
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution 3.0 License.
Eye Reports [eISSN 2039-4756] is a new Open Access, online-only, peer-reviewed journal.